CEF19, Epstein-Barr Virus latent NA-3A (458-466)

CEF19, Epstein-Barr Virus latent NA-3A (458-466) is a single peptide epitope, YPLHEQHGM, representing residues 458-466 of the type 1 Epstein-Barr Virus (EBV) nuclear antigen 3A protein (B95.8 strain) . CEF19, Epstein-Barr Virus latent NA-3A (458-466) can significantly affect cytotoxic T-lymphocyte (CTL) recognition[1].

Product Specifications

CAS Number

[157876-41-0]

UNSPSC

12352209

Target

EBV

Type

Peptides

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/cef19-epstein-barr-virus-latent-na-3a-458-466.html

Solubility

H2O

Smiles

CSCC[C@@H](C(O)=O)NC(CNC([C@H](CC1=CNC=N1)NC([C@H](CCC(N)=O)NC([C@H](CCC(O)=O)NC([C@H](CC2=CNC=N2)NC([C@H](CC(C)C)NC([C@H]3N(C([C@H](CC4=CC=C(O)C=C4)N)=O)CCC3)=O)=O)=O)=O)=O)=O)=O

Molecular Formula

C49H70N14O14S

Molecular Weight

1111.23

References & Citations

[1]Lee SP, et al. Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.01-positive African population. Eur J Immunol. 1995 Jan;25 (1) :102-10.